Renaissance Technologies’s CollPlant Biotechnologies OPHI Stock Holding History

Renaissance Technologies’s Portfolio OPHI Stock Details OPHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$38.9K	Buy	10,300 +4,150	+67%	+$14.3K	﹤0.01%	3099
2026 Q2	$21.5K	Buy	6,150 +4,470	+266%	+$17.2K	﹤0.01%	3089
2026 Q1	$9K	Sell	1,680 -80	-5%	-$807	﹤0.01%	3201
2025 Q4	$24.6K	Sell	1,760 -430	-20%	-$8.8K	﹤0.01%	3134
2025 Q3	$58.9K	Sell	2,190 -1,970	-47%	-$47K	﹤0.01%	3320
2025 Q2	$56.6K	Buy	4,160 +3,130	+304%	+$64.8K	﹤0.01%	3378
2025 Q1	$26.6K	Sell	1,030 -30	-3%	-$1.06K	﹤0.01%	3346
2024 Q4	$38.2K	Buy	+1,060	New	+$43.1K	﹤0.01%	3421
2021 Q4	–	Sell	-1,000	Closed	-$169K	–	3934
2021 Q3	$169K	Buy	+1,000	New	+$180K	﹤0.01%	3235
2020 Q4	–	Sell	-1,280	Closed	-$107K	–	3411
2020 Q3	$107K	Buy	1,280 +10	+0.8%	+$900	﹤0.01%	3209
2020 Q2	$127K	Buy	+1,270	New	+$131K	﹤0.01%	3238

Other funds holding OPHI

St. Denis J. Villere & Co New Orleans, Louisiana $775M AUM 13.27% 1-Year Est. Return

Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

Parkside Financial Bank & Trust Saint Louis, Missouri $1.51B AUM 17.86% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Strive Financial Group Carmel, Indiana $316M AUM 17.91% 1-Year Est. Return

Renaissance Technologies's OPHI Position: Q3 2026 in Review

Renaissance Technologies increased its CollPlant Biotechnologies (OPHI) stake by 67% in Q3 2026, buying an estimated $14.3K and bringing the position to 10,300 shares worth $38.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3099.

Renaissance Technologies first reported a position in OPHI in Q2 2020 and has held it in 11 quarters since. The position peaked at $169K in Q3 2021. 7 funds tracked by Wall St. Rank hold OPHI as of Q3 2026.

Renaissance Technologies held 10,300 shares of CollPlant Biotechnologies worth $38.9K as of Q3 2026.
Renaissance Technologies bought 4,150 CollPlant Biotechnologies shares in Q3 2026, an estimated $14.3K.
CollPlant Biotechnologies made up ﹤0.01% of Renaissance Technologies's portfolio in Q3 2026, its #3099 holding.
Renaissance Technologies first reported a position in CollPlant Biotechnologies in Q2 2020 and has held it in 11 quarters since.
Renaissance Technologies's CollPlant Biotechnologies position peaked at $169K in Q3 2021.
7 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q3 2026.

Based on Renaissance Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.